Bronwen Bastone is CPO at Enfusion, Inc. (ENFN). They have made 11 open-market trades across 1 company since 2023, most recently 2025-04-21.
CIK 0001927636
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 11 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ENFN | 221,875 | $2.4M |
Shares reported on the most recent Form 4, priced at the 2025-03-07 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ENFN | SELL | 2025-03-05 | 2025-03-07 | $11.38 | $36K | +0.1% | -4.3% | N/A |
| ENFN | SELL | 2025-03-03 | 2025-03-05 | $11.48 | $24K | -2.7% | -6.9% | N/A |
| ENFN | SELL | 2025-01-07 | 2025-01-10 | $10.13 | $8K | +2.8% | +2.8% | -0.1% |
| ENFN | SELL | 2024-09-10 | 2024-09-12 | $8.12 | $26K | +17.8% | +9.3% | +31.0% |
| ENFN | SELL | 2024-06-18 | 2024-06-21 | $8.13 | $468K | +3.6% | +11.1% | +3.3% |
| ENFN | SELL | 2024-05-20 | 2024-05-22 | $9.55 | $651K | -3.9% | -10.6% | -13.2% |
| ENFN | SELL | 2024-01-08 | 2024-01-10 | $9.09 | $7K | +3.0% | -4.1% | +10.9% |
| ENFN | SELL | 2023-08-14 | 2023-08-15 | $7.89 | $323 | +7.4% | +9.8% | +22.5% |
| ENFN | SELL | 2023-08-11 | 2023-08-14 | $8.10 | $356 | +7.3% | +7.3% | +22.3% |
| ENFN | SELL | 2023-08-10 | 2023-08-11 | $8.08 | $404 | +8.0% | +10.3% | +13.4% |
| ENFN | SELL | 2023-08-09 | 2023-08-10 | $8.32 | $458 | +6.6% | +10.5% | +11.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.